The company has received a cash grant from the UK government to adapt its cell preservation gel for coronavirus testing samples.
A
Atelerix
Atelerix provides a gel-based system for storing and transporting biological samples at room temperature.
London, UK—Founded 2017
Atelerix develops a gel-based system designed for storing and transporting cells and tissues at room temperature without freezing.
Filed accounts
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Current assets
Members only
Cash, assets and headcount from Atelerix's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Team
MM
Mick McLean
CEO
Mick previously served as CEO of Atelerix and Pro-Cure Therapeutics, alongside holding chairman roles at Link Technologies and Abeterno. He is currently retired.
LinkedInInvestors
Funding history
The funding round was led by UK Innovation & Science Seed Fund to support the commercialisation of the company products.